Selective inhibitor of the alanine-serine-cysteine transporter 2 (ASCT2 or SLC1A5; IC 50 = 9.0 µM rat and 9.6 µM human). It inhibited the uptake of both glutamine and possibly other amino acids in human cancer cells and reduced in vitro viability by at least 20% in more than half of 29 cancer...
Know who made it. See the evidence. Buy through one marketplace.
Selective inhibitor of the alanine-serine-cysteine transporter 2 (ASCT2 or SLC1A5; IC 50 = 9.0 µM rat and 9.6 µM human). It inhibited the uptake of both glutamine and possibly other amino acids in human cancer cells and reduced in vitro viability by at least 20% in more than half of 29 cancer cell lines screened. V-9302 decreased mTOR activity, elevated autophagy, and increased oxidative stress in multiple animal cancer models. Suppressed osteoclast differentiation in vitro and improved ovariectomy-induced bone loss in mice
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
